Abbott Laboratories

ABT | NYSE | 48 Followers
$123.64 -0.83% -$1.03
Follow
Overview Metrics Financials
Loading...

Fair Price

$778.91
Overvalued by 8.0%
Za prikaz poštene cene delnice morate biti član Bulios Black.

Profile

Abbott Laboratories (ABT) is an American healthcare company with a global presence. The company specializes in the development, manufacturing, and distribution of a wide range of healthcare products and medications. Abbott focuses on innovative pharmaceuticals, diagnostic equipment, medical devices, and nutritional products. Their portfolio includes products for various areas of healthcare, such as cardiovascular care, diabetes care, gastroenterology, infectious disease diagnostics, maternal and pediatric care, and many others. The company has a long history and is known for its quality, reliability, and research in healthcare innovations. Abbott Laboratories plays a crucial role in improving people's health worldwide and collaborates with physicians and healthcare professionals on the development of medications and diagnostic solutions. Abbott Laboratories (ABT) shares are an interesting choice for investors who follow the healthcare sector and seek investment opportunities in a key company operating in the healthcare industry.

Feed

Read More

Laboratorij Abbott je zaradi dobre prodaje medicinskih pripomočkov presegel pričakovanja glede četrtletnega dobička.

Posebej uspešna je bila prodaja izdelkov za spremljanje glukoze.

Povečanje povpraševanja po medicinskih posegih je podprlo splošno rast.

Letni dobiček v višini 98 centov na delnico je za 3 cente presegel ocene analitikov.

Abbott Laboratories $ABT je povišal celoletno...
Read more
0
Share
Read More

📈 Naložbeni dragulji v zdravstvu 📈

Pozdravljeni BuliosiansDanes imam tukaj tri kralje zdravstvene industrije! 💰

Johnson & Johnson $JNJ
DružbaJNJ je zveč kot 62 leti stalnih dividend in bonitetno oceno AAAzanimiva izbira. Podjetje se osredotoča na farmacevtske izdelke, medicinske pripomočke in tehnologijo ter poudarja doslednost in trajnost. Zzgodovinsko nizkim prihodnjim P/E ...
Read more
0
Share
Don't have an account? Join us

Log in to Bulios

Continue with Google Continue with Apple Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade